FDA Investigator Stephanie A Jameson
Stephanie A Jameson has inspections in 2 countries as of 14 Nov 2023. Stephanie A Jameson has collaborated with a combined 1409 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
30
Last Inspection Date:
14 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Abby M Miller,
Abigail A Andersen,
Amber M Howell,
Amy R Glynn,
Arie R Dyk,
Ashleigh P Barkans,
Astrida B Mattson,
Barbara J Rincon,
Brenda K Alford,
Bryan L Mcguckin,
Courtney R Ingalsbe,
Crystal A Harlan,
David A Pettenski,
Dawn E Barkans,
Debra D Devlieger,
Dennis R Hudson,
Devon M Shoop,
Don A Brunssen,
Donald B Mckechnie,
Elizabeth A Sheller,
Elizabeth S Howell,
Emal Wahab,
Gavin W Pierce,
Gina C Collins,
Gloria J Baca, MS,
Graham N Giesen,
Harmon M Blanch,
Heika R Tait,
James C Henry,
James S Cartwright,
Jean R Mccurry,
Jeanne M Weishaar,
Jeannine K Wooten,
Jeff A Gard,
Jeffrey J Leclair,
Jessica B Clark,
Jinkee Mvila Binayug,
John W Banks,
Jonathan T Little,
Jose O Caraballo Rivera,
Julia E Chervoni,
Kaitlyn R Kornberg,
Karen L Rothschild,
Kay,
Kelsey M Bishop,
Kimberly J Proctor Jones,
Lenita R Silvera,
Lesley A Swanson,
Lester O Boian,
Lisa A Bowden,
Lisa K Capron,
Mai Hang,
Margo C Jones,
Margo Cl Jones,
Marijo B Kambere, PhD,
Matthew R Barr,
Michael J Lackey,
Michael S Hudson,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Paul F Rader,
Paula J Wilkerson,
Peter T Regan,
Rebecca A Sletner,
Robert F Hennes,
S Lori Brown, PhD MPH,
Savini,
Shannon J Hall,
Shelagh D Schopen,
Sonia R Peterson,
State Agency,
Stephanie L Kelly,
Thomas C Mclean, CFS,
Timothy D Evans,
Timothy S Williamson,
Vitaliy N Guyvan,
William C Hughes,
Young M Yoon,
Zachary P Wachlarowicz
Stephanie A Jameson's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2023 | FDA 483 | Highland Laboratories Inc - Form 483, 2023-03-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more